Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00003683What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer UNICANCER 40
Not applicableStudy completedNCT02156895What this trial is testingPost Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South KoreaWho this might be right forAdvanced Renal Cell Carcinoma Pfizer 111
Testing effectiveness (Phase 2)WithdrawnNCT00311545What this trial is testingS0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00796757What this trial is testingAvastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).Who this might be right forRenal Cell Cancer Hoffmann-La Roche 146
Early research (Phase 1)Looking for participantsNCT07179770What this trial is testingEffects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma NYU Langone Health 12
Large-scale testing (Phase 3)Looking for participantsNCT03592472What this trial is testingPazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Who this might be right forRenal Cell Carcinoma Xynomic Pharmaceuticals, Inc. 413
Testing effectiveness (Phase 2)Study completedNCT00002466What this trial is testingCombination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerWho this might be right forKidney CancerSarcoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00025519What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney CancerWho this might be right forKidney Cancer Fox Chase Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00626509What this trial is testingSunitinib Before or After Surgery in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Gruppo Italiano Carcinoma Renale 110
Not applicableStudy completedNCT03161145What this trial is testingObserve the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has SpreadWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 297
Early research (Phase 1)Ended earlyNCT02543645What this trial is testingVarlilumab and Atezolizumab in Patients With Advanced CancerWho this might be right forCarcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more Celldex Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00053209What this trial is testingPemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 46
Testing effectiveness (Phase 2)UnknownNCT04049344What this trial is testingDecitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06863311What this trial is testingTrial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCCWho this might be right forAdvanced Renal Cell CarcinomaMetastatic Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Karie Runcie 70
Early research (Phase 1)Ended earlyNCT03145909What this trial is testingA Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)Who this might be right forAdvanced Solid Tumors Cancer AbbVie 19
Testing effectiveness (Phase 2)Ended earlyNCT00112905What this trial is testingSorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumWho this might be right forAdenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more National Cancer Institute (NCI) 27
Not applicableLooking for participantsNCT04115254What this trial is testingStereotactic Magnetic Resonance Guided Radiation TherapyWho this might be right forPancreas CancerLung CancerRenal Cancer+10 more Dana-Farber Cancer Institute 397
Not applicableStudy completedNCT04883827What this trial is testingDisease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney CancerWho this might be right forRenal Cell Carcinoma Vanderbilt-Ingram Cancer Center 180
Large-scale testing (Phase 3)Study completedNCT02716792What this trial is testingEvaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast CancerWho this might be right forPain; Bone Neoplasms; Neoplasm Metastasis Hoffmann-La Roche 334